Skip to main content

Table 2 Baseline blood pressure, ejection fraction, and related laboratory results (N = 1,067)

From: Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare system

 

Mean

Median

Standard deviation

Systolic Blood pressure (mmHg)

127

125

13.82

Diastolic Blood pressure (mmHg)

77

78

9.39

Ejection fraction (%)

54

55

4.169

B-type natriuretic peptide level (pg/mL)

139

0

0

Troponin T (ng/mL)

1.5

43

0

Creatine kinase (U/L)

69.07

160

0

Calcium level (mmol/L)

2.28

2.25

0.138

Magnesium level (mmol/L)

0.8

0.84

8.92

Potassium level (mmol/L)

4.14

4.2

0.452

Sodium level (mmol/L)

139.76

140

3.72

Albumin (g/L)

39.85

39

5.89

Hemoglobin (g/L)

119.05

117

17.22

Hematocrit (L/L)

0.36

0.361

0.045

Serum creatinine (μmol/L)

62.38

60

16.64

GFR (mL/min/1.73 m2)

50.25

60

0.816

AST (U/L)

28.1

20

27.36

ALT (U/L)

26.42

17.05

26.23

Total Bilirubin (μmol/L)

7.02

6

4.87

INR

1.12

1

0.102

Prothrombin time (s)

30.40

34.35

4.76

  1. ALT alanine transaminase, AST aspartate aminotransferase, GFR glomerular filtration rate, INR international normalized ratio